Q32 Bio, Inc. (QTTB)
9.55
+0.21
(+2.25%)
USD |
NASDAQ |
Nov 10, 09:52
Q32 Bio Cash and Short Term Investments (Quarterly) : 289.59M for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 289.59M |
| June 30, 2026 | 106.27M |
| March 31, 2026 | 50.75M |
| December 31, 2025 | 48.30M |
| September 30, 2025 | 49.04M |
| June 30, 2025 | 54.83M |
| March 31, 2025 | 65.48M |
| December 31, 2024 | 77.96M |
| September 30, 2024 | 89.08M |
| June 30, 2024 | 107.65M |
| March 31, 2024 | 135.31M |
| December 31, 2023 | 25.62M |
| September 30, 2023 | 103.30M |
| June 30, 2023 | 127.07M |
| March 31, 2023 | 150.02M |
| December 31, 2022 | 175.03M |
| September 30, 2022 | 201.07M |
| June 30, 2022 | 225.52M |
| Date | Value |
|---|---|
| March 31, 2022 | 256.13M |
| December 31, 2021 | 155.87M |
| September 30, 2021 | 187.55M |
| June 30, 2021 | 213.29M |
| March 31, 2021 | 188.65M |
| December 31, 2020 | 217.43M |
| September 30, 2020 | 178.00M |
| June 30, 2020 | 206.64M |
| March 31, 2020 | 234.93M |
| December 31, 2019 | 262.39M |
| September 30, 2019 | 269.67M |
| June 30, 2019 | 295.80M |
| March 31, 2019 | 187.97M |
| December 31, 2018 | 214.74M |
| September 30, 2018 | 237.54M |
| June 30, 2018 | 255.51M |
| March 31, 2018 | 116.73M |
| December 31, 2017 | 129.66M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 474.11M |
| Beam Therapeutics, Inc. | 1.044B |
| Prime Medicine, Inc. | 95.07M |
| Korsana Biosciences, Inc. | 456.22M |
| Prelude Therapeutics, Inc. | 151.76M |